Fly News Breaks for May 14, 2018
NBIX
May 14, 2018 | 07:54 EDT
Oppenheimer analyst Jay Olson raised his price target for Neurocine to $120 from $110 based on greater confidence in Tourette syndrome. The analyst reiterates an Outperform rating on the shares.
News For NBIX From the Last 2 Days